×
返回 Agenda
Regulatory Affairs: Part 1: The IND – Investigational New Drug Application
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President, Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs, Entrada Therapeutics, United States
Regulatory Affairs: Part 1: The IND – Investigational New Drug Application